<DOC>
	<DOCNO>NCT01028170</DOCNO>
	<brief_summary>The purpose study compare high dose furosemide combination low volume hypertonic saline solution ( 2.4 % ) intermittent pulse dose furosemide patient pre treatment kidney function impairment . The hypothesis provide effective diuretic response beneficial effect preservation renal function compare pulse furosemide patient pre-treatment renal impairment ( GFR &lt; 60 mL/min ) .</brief_summary>
	<brief_title>Safety Efficacy Low Dose Hypertonic Saline Solution High Dose Furosemide Congestive Heart Failure</brief_title>
	<detailed_description>Currently , congestive heart failure ( CHF ) fast grow heart-related diagnosis North America , chance person experience lifetime around 20 % . In patient CHF , acute decompensation require hospitalization common . Patients renal insufficiency susceptible worsen renal function overt renal failure relation episode decompensated heart failure . Thus , great need treatment help patient renal dysfunction simultaneously protect renal deterioration . Preliminary evidence indicate hypertonic saline solution ( HSS ) combine high dose loop diuretic may improve prognosis patient CHF . In two separate study , treatment find alleviate symptom CHF , significantly reduce hospital length stay , well reduce morbidity mortality subsequent hospital stay . So far , available study demonstrate renal function compromise use HSS high dose furosemide treatment CHF . Preliminary data institution suggest low volume HSS combine high dose furosemide may beneficial patient renal insufficiency . Hypothesis : High dose furosemide combination low volume HSS provide effective diuretic response beneficial effect preservation renal function hospital compare pulse furosemide patient pre-treatment renal impairment ( GFR &lt; 60 mL/min ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Uncompensated CHF Framingham Criteria HF 2 Major 1 Major 2 minor Major criterion : Paroxysmal nocturnal dyspnea Neck vein distention Rales Radiographic cardiomegaly ( increase heart size chest radiography ) Acute pulmonary edema S3 gallop Increased central venous pressure ( &gt; 16 cm H2O right atrium ) Hepatojugular reflux Weight loss &gt; 4.5 kg 5 day response treatment Minor criterion : Bilateral ankle edema Nocturnal cough Dyspnea ordinary exertion Hepatomegaly Pleural effusion Decrease vital capacity one third maximum record Tachycardia ( heart rate &gt; 120 beats/min . ) No Ejection Fraction Inclusion Criteria GFR Â£ 60 mL/min GFR ( mL/min/1.73 m2 ) = 186 x ( Scr ) 1.154 x ( Age ) 0.203 x ( 0.742 female ) x ( 1.212 African American ) ( conventional unit ) . Informed consent Patients Acute Coronary Syndrome Post op patient within 90 day previous surgery Patients currently dialysis Hospice patient Patients &lt; 18 year age .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Congestive Heart Failure</keyword>
	<keyword>Renal Insufficiency</keyword>
	<keyword>Cardio-renal Syndrome</keyword>
</DOC>